[{"Assets_0_Q2_USD":172918000.0,"CommonStockSharesOutstanding_0_Q2_shares":73580000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-32767000.0,"NetIncomeLoss_2_Q2_USD":-39417000.0,"NetIncomeLoss_1_Q2_USD":-18367000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":10000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":10000000.0,"StockholdersEquity_0_Q2_USD":126867000.0,"Ticker":"VSTM","CIK":"1526119","name":"VERASTEM, INC.","OfficialName":"Verastem Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309307156.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]